ES8607255A1 - Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina - Google Patents

Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina

Info

Publication number
ES8607255A1
ES8607255A1 ES85541445A ES541445A ES8607255A1 ES 8607255 A1 ES8607255 A1 ES 8607255A1 ES 85541445 A ES85541445 A ES 85541445A ES 541445 A ES541445 A ES 541445A ES 8607255 A1 ES8607255 A1 ES 8607255A1
Authority
ES
Spain
Prior art keywords
sulphate
tetrahydro
procedure
biopteline
eritro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES85541445A
Other languages
English (en)
Spanish (es)
Other versions
ES541445A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Publication of ES8607255A1 publication Critical patent/ES8607255A1/es
Publication of ES541445A0 publication Critical patent/ES541445A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES85541445A 1984-03-24 1985-03-21 Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina Expired ES8607255A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59056584A JPS60199889A (ja) 1984-03-24 1984-03-24 ５，６，７，８−テトラヒドロ−ｌ−エリスロ−ビオプテリンの硫酸塩およびその製法

Publications (2)

Publication Number Publication Date
ES8607255A1 true ES8607255A1 (es) 1986-05-16
ES541445A0 ES541445A0 (es) 1986-05-16

Family

ID=13031220

Family Applications (1)

Application Number Title Priority Date Filing Date
ES85541445A Expired ES8607255A1 (es) 1984-03-24 1985-03-21 Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina

Country Status (7)

Country Link
US (1) US4649197A (esLanguage)
EP (1) EP0156330B1 (esLanguage)
JP (1) JPS60199889A (esLanguage)
AT (1) ATE47141T1 (esLanguage)
CA (1) CA1250837A (esLanguage)
DE (1) DE3573601D1 (esLanguage)
ES (1) ES8607255A1 (esLanguage)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853711T2 (de) * 1987-11-30 1996-01-11 Vitamin Kenkyusho Kk Zwischenverbindungen für die Synthese von 5,6,7,8-Tetrahydro-L-erythro-biopterin und seiner Derivate.
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
AU2004291149C1 (en) 2003-11-17 2021-01-21 Biomarin Pharmaceutical Inc. Methods and Compositions for the Treatment of Metabolic Disorders
EP2436379A1 (en) 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stable tablet formulation
WO2006063215A2 (en) * 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
CA2631740A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
CA2675134A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Pterin analogs
KR20100016445A (ko) 2007-04-11 2010-02-12 바이오마린 파머수티컬 인크. 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법
JP2011508775A (ja) * 2008-01-03 2011-03-17 ビオマリン プハルマセウトイカル インコーポレイテッド Ｂｈ４応答性状態を治療するためのプテリン類似体
WO2009088979A1 (en) * 2008-01-07 2009-07-16 Biomarin Pharmaceutical Inc. Method of synthesizing tetrahydrobiopterin
CN102443006B (zh) 2010-10-13 2016-02-24 因华生技制药股份有限公司 (6r)-四氢生物喋呤盐酸盐的制备方法
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
WO2019175328A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4pathwayactivationandusethereoffortreatingcancer
WO2019175332A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4 pathway inhibition and use thereof for treating t-cell mediated autoimmune diseases or hypersensitivity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA487930A (en) * 1952-11-11 Roth Barbara Salts of substituted pteridines and method of preparing the same
US3468886A (en) * 1967-10-23 1969-09-23 Us Health Education & Welfare Tetrahydrohomofolic acid sulfate and synthesis thereof
DE2967143D1 (en) * 1978-12-18 1984-08-30 Wachter Helmut Diagnostic method, especially for the early recognition of malignant tumors and/or viral diseases, and means to carry it out
JPS5883691A (ja) * 1981-11-13 1983-05-19 Kanegafuchi Chem Ind Co Ltd １′，２′−ジアシル−（６ｒ，ｓ）−５，６，７，８−テトラヒドロ−ｌ−ビオプテリンおよびその製法
JPS60178887A (ja) * 1984-02-23 1985-09-12 Kanegafuchi Chem Ind Co Ltd ５，６，７，８−テトラヒドロ−ｌ−ビオプテリンの製造法

Also Published As

Publication number Publication date
EP0156330B1 (en) 1989-10-11
CA1250837A (en) 1989-03-07
JPS60199889A (ja) 1985-10-09
EP0156330A2 (en) 1985-10-02
US4649197A (en) 1987-03-10
JPH0469157B2 (esLanguage) 1992-11-05
ES541445A0 (es) 1986-05-16
EP0156330A3 (en) 1986-10-08
ATE47141T1 (de) 1989-10-15
DE3573601D1 (en) 1989-11-16

Similar Documents

Publication Publication Date Title
ES8607255A1 (es) Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
IE39517B1 (en) Double salts of s-adenosyl-l-methhionine
AR248407A1 (es) Un procedimiento para la preparacion de la forma monohidratada cristalina de una 1-carbacefalosporina.
IE830926L (en) Crystalline benzenesulfonate salts of sultamicillin
MX9200063A (es) Derivados de acidos tetrahidrofolicos y procedimiento para su preparacion.
ES8801235A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
SE8403871D0 (sv) Kemisk forening, anvendbar som mellanprodukt vid framstellning av vissa cyanoguanidinderivat
ES8704965A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES8703871A1 (es) Procedimiento de obtener alcaloides del tipo de la berberina y similares.
IE791879L (en) Corticoid-21-sulphopropionates
NO873784D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftalen- og indanderivater.
FI864970A0 (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
JPS6442472A (en) Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
ES8801921A1 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
GT198274393A (es) Procedimiento e intermedios para produccion de 6-(2-amino-2-fenilacetamido) penicilanatos de 1,1-dioxopenicilanoiloxime-tilo.
ES8504182A1 (es) Procedimiento para preparar nuevos derivados de piperidina
ES2032215T3 (es) Preparacion de isotiazolonas.
ES8504174A1 (es) Un procedimiento para la preparacion de derivados de pirazolo-quinolinas.
ES8505370A1 (es) Procedimiento para preparar nuevos compuestos heterociclicos
ES8609340A1 (es) Sal sodica del acido d-6-(a-(2-oxo-3-furfurilidenaminoimida-zolidin-1-il)-carbonilamino)-tienil-2-acetamido)-penicilani-co
SU1744946A1 (ru) Способ получения смеси изомеров 9-(2-хлорэтил)-7-нитрозо-l-гомоцитруллина и 9-(2-хлорэтил)-9-нитрозо-l-гомоцитруллина
ES8607322A1 (es) Un procedimiento para la preparacion de un compuesto de ce- falosporina
JPS5275694A (en) Production of gypsum
ES8602780A1 (es) Procedimiento de preparar epimeros de aminoftaluroisoquino- linas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301